In the absence of endogenous mouse apolipoprotein E, apolipoprotein E*2(Arg-158 replaced by Cys) transgenic mice develop more severe hyperlipoproteinemia than apolipoprotein E*3-Leiden transgenic mice.
1996
Vlijmen B.J.M. van | Dijk K.W. van | Hof H.B. van't | Gorp P.J.J. van | Zee A. van der | Boom H. van der | Breuer M.L. | Hofker M.H. | Havekes L.M.
Apolipoprotein E*2(Arg-158 replaced by Cys) (APOE*2) transgenic mice were generated and compared to the previously generated apolipoprotein E*3-Leiden (APOE*3-Leiden) transgenic mice to study the variable expression of hyperlipoproteinemia associated with these two APOE variants. In the presence of the endogenous mouse Apoe gene, the expression of the APOE*3-Leiden gene resulted in slightly elevated levels of serum cholesterol as compared with control mice (2.7 +/- 0.5 versus 2.1 +/-0.2 mmol/liter, respectively), whereas the expression of the APOE*2(Arg-158 replaced Cys) gene did not affect serum cholesterol levels, even after high/fat cholesterol feeding. The extreme cholesterol level usually found in apoE-deficient mice (Apoe-1- mice; 23.6 +/- 5.0 mmol/liter) could be rescued by introducing the APOE*3-Leiden gene (APOE*3-Leiden.Apoe-1-; 3.6 +/- 1.5 mmol/liter), whereas the expression of the APOE*2 (Arg- 158 replaced Cys) gene in Apoe -1- mice minimally reduced serum cholesterol levels (APOE*2.Apoe-1-; 16.6 +/- 2.9 mmol/liter). In vivo very low density lipoprotein (LDL) turnover studies revealed that APOE*2.Apoe-1- VLDL and APOE*3-Leiden.Apoe -1-VLDL display strongly reduced fractional catabolic rates as compared with control mouse VLDL (4.0 and 6.1 versus 22.1 pools/h). In vitro low density lipoprotein (VLDL) receptor binding studies using HepG2 and J774 cells showed that APOE*2.Apoe-1- VLDL is completely defective in binding to the LDL receptor, whereas APOE*3-Leiden.Apoe-1- VLDL still displayed a considerable binding activity to the LDL receptor. After transfection of APOE*2.Apoe-1- and APOE*3-Leiden.Apoe-1- mice with adenovirus carrying the gene for the receptor-associated protein (AdCMV-RAP), serum lipid levels strongly increased (15.3 to 42.8 and 1.4 to 15.3 mmol/liter for cholesterol and 5.0 to 35.7 and 0.3 to 20.7 mmol/liter for triglycerides, respectively).
显示更多 [+] 显示较少 [-]